VHCP Management II as of June 30, 2019
Portfolio Holdings for VHCP Management II
VHCP Management II holds 21 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 18.3 | $58M | 504k | 115.15 | |
| Shockwave Med (SWAV) | 16.2 | $52M | 901k | 57.09 | |
| Biohaven Pharmaceutical Holding | 13.3 | $42M | 963k | 43.79 | |
| Obseva Sa | 8.0 | $26M | 2.3M | 11.31 | |
| Axsome Therapeutics (AXSM) | 7.2 | $23M | 893k | 25.75 | |
| Ra Pharmaceuticals | 6.4 | $20M | 677k | 30.07 | |
| Zogenix | 5.5 | $17M | 362k | 47.78 | |
| Tricida | 5.3 | $17M | 429k | 39.46 | |
| BioCryst Pharmaceuticals (BCRX) | 3.4 | $11M | 2.9M | 3.79 | |
| Constellation Pharmceticls I | 2.8 | $8.9M | 727k | 12.28 | |
| Kalvista Pharmaceuticals (KALV) | 2.6 | $8.3M | 377k | 22.15 | |
| Kiniksa Pharmaceuticals (KNSA) | 2.6 | $8.2M | 609k | 13.54 | |
| Spero Therapeutics (SPRO) | 1.7 | $5.5M | 474k | 11.51 | |
| Protagonist Therapeutics (PTGX) | 1.6 | $5.2M | 427k | 12.11 | |
| La Jolla Pharmaceuticl Com Par | 1.5 | $4.8M | 518k | 9.25 | |
| Milestone Pharmaceuticals (MIST) | 1.3 | $4.0M | 149k | 27.15 | |
| Marinus Pharmaceuticals | 1.0 | $3.1M | 744k | 4.15 | |
| Bellerophon Therapeutics | 0.8 | $2.5M | 4.1M | 0.60 | |
| Kadmon Hldgs | 0.2 | $514k | 250k | 2.06 | |
| Gemphire Therapeutics | 0.1 | $382k | 472k | 0.81 | |
| Proteostasis Therapeutics In | 0.0 | $128k | 131k | 0.98 |
